124 related articles for article (PubMed ID: 10063270)
21. Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients.
Hurteau JA; Simon HU; Kurman C; Rubin L; Mills GB
Am J Obstet Gynecol; 1994 Mar; 170(3):918-28. PubMed ID: 8141226
[TBL] [Abstract][Full Text] [Related]
22. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
Harlin H; Kuna TV; Peterson AC; Meng Y; Gajewski TF
Cancer Immunol Immunother; 2006 Oct; 55(10):1185-97. PubMed ID: 16468035
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
24. FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients.
Reijnhart RM; Bieber MM; Teng NN
Immunobiology; 1994 Aug; 191(1):1-8. PubMed ID: 7806256
[TBL] [Abstract][Full Text] [Related]
25. Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets.
Gallinelli A; Chiossi G; Giannella L; Marsella T; Genazzani AD; Volpe A
Gynecol Endocrinol; 2004 Mar; 18(3):144-51. PubMed ID: 15255283
[TBL] [Abstract][Full Text] [Related]
26. Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.
Zeimet AG; Widschwendter M; Knabbe C; Fuchs D; Herold M; Müller-Holzner E; Daxenbichler G; Offner FA; Dapunt O; Marth C
J Clin Oncol; 1998 May; 16(5):1861-8. PubMed ID: 9586902
[TBL] [Abstract][Full Text] [Related]
27. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
28. [-Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma-].
Radke J; Schmidt D; Böhme M; Schmidt U; Weise W; Morenz J
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):83-7. PubMed ID: 8647364
[TBL] [Abstract][Full Text] [Related]
29. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
30. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
31. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
Ioannides CG; Rashed S; Fisk B; Fan D; Itoh K; Freedman RS
Lymphokine Cytokine Res; 1991 Aug; 10(4):307-15. PubMed ID: 1932375
[TBL] [Abstract][Full Text] [Related]
32. Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study.
Lacki J; Markowska J; Wiktorowicz K
Eur J Gynaecol Oncol; 1992; 13(6):475-9. PubMed ID: 1473526
[TBL] [Abstract][Full Text] [Related]
33. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12-mediated tumoricidal activity of patient lymphocytes in an autologous in vitro ovarian cancer assay system.
DeCesare SL; Michelini-Norris B; Blanchard DK; Barton DP; Cavanagh D; Roberts WS; Fiorica JV; Hoffman MS; Djeu JY
Gynecol Oncol; 1995 Apr; 57(1):86-95. PubMed ID: 7705706
[TBL] [Abstract][Full Text] [Related]
35. Association of leptin with inflammatory cytokines and lymphocyte subpopulations in peritoneal fluid of patients with endometriosis.
Milewski Ł; Barcz E; Dziunycz P; Radomski D; Kamiński P; Roszkowski PI; Korczak-Kowalska G; Malejczyk J
J Reprod Immunol; 2008 Oct; 79(1):111-7. PubMed ID: 18814918
[TBL] [Abstract][Full Text] [Related]
36. [Effects of pregnancy on the ROS, NO, cytokine levels and lymphocytes activation from mouse peripheral blood].
He F; Chen DJ; Li LY; Chen QX
Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):453-6. PubMed ID: 24103126
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
38. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia.
Walker C; Bauer W; Braun RK; Menz G; Braun P; Schwarz F; Hansel TT; Villiger B
Am J Respir Crit Care Med; 1994 Oct; 150(4):1038-48. PubMed ID: 7921434
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppression related to ascitic fluid in patients with ovarian carcinoma.
Marotti T; Hrsak I; Krusić J; Deverić G
Oncology; 1982; 39(5):298-303. PubMed ID: 7048173
[TBL] [Abstract][Full Text] [Related]
40. CD4(+) CD25(high) Foxp3(+) cells increased in the peritoneal fluid of patients with endometriosis.
Podgaec S; Rizzo LV; Fernandes LF; Baracat EC; Abrao MS
Am J Reprod Immunol; 2012 Oct; 68(4):301-8. PubMed ID: 22817851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
